Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish oil (Omacor) for prevention of post‑CABG atrial fibrillation – cellular mechanisms
2006-001451-35Phase 4Terminated
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Nov 2006
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of omega-3-acid triglycerides in Atrial fibrillation (AFib), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Incidence of atrial fibrillation after CABG surgery. Started Nov 2006; status: terminated.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2006-001451-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001451-35.